These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 11064469

  • 1. Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study.
    Martino R, Martín-Henao G, Sureda A, Altés A, Canals C, Brunet S, Sierra J.
    Haematologica; 2000 Nov; 85(11):1165-71. PubMed ID: 11064469
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.
    Urbano-Ispizua A, Solano C, Brunet S, de la Rubia J, Odriozola J, Zuazu J, Figuera A, Caballero D, Martínez C, García J, Sanz G, Torrabadella M, Alegre A, Pérez-Oteiza J, Jurado M, Oyonarte S, Sierra J, García-Conde J, Rozman C.
    Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337
    [Abstract] [Full Text] [Related]

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.
    Finke J, Brugger W, Bertz H, Behringer D, Kunzmann R, Weber-Nordt RM, Kanz L, Mertelsmann R.
    Bone Marrow Transplant; 1996 Dec; 18(6):1081-6. PubMed ID: 8971376
    [Abstract] [Full Text] [Related]

  • 5. Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation.
    Ferrá C, Rodríguez-Luaces M, Gallardo D, Encuentra M, Martín-Henao GA, Peris J, Ancín I, Sarrá J, Berlanga JJ, García J, Grañena A.
    Bone Marrow Transplant; 2001 Nov; 28(10):963-8. PubMed ID: 11753552
    [Abstract] [Full Text] [Related]

  • 6. Mixed chimerism is frequent after allogeneic peripheral blood stem cell transplantation with positive CD34 selection, and is not reverted by low doses of donor T-cells add-back.
    Rodríguez-Luaces M, Ferrá C, Martín-Henao G, Berlanga JJ, Grañena A, Gallardo D.
    Eur J Haematol; 2004 Sep; 73(3):162-8. PubMed ID: 15287912
    [Abstract] [Full Text] [Related]

  • 7. T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.
    Montero A, Savani BN, Shenoy A, Read EJ, Carter CS, Leitman SF, Mielke S, Rezvani K, Childs R, Barrett AJ.
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1318-25. PubMed ID: 17162214
    [Abstract] [Full Text] [Related]

  • 8. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM, Kusnierz-Glaz C, Valone F, Stockerl-Goldstein KE, Hu WW, Johnston L, Blume KG, Strober S, Negrin RS.
    Cancer; 2001 Jun 15; 91(12):2205-13. PubMed ID: 11413507
    [Abstract] [Full Text] [Related]

  • 9. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
    O'Donnell PV, Jones RJ, Vogelsang GB, Seber A, Ambinder RF, Flinn I, Miller C, Marcellus DC, Griffin C, Abrams R, Braine HG, Grever M, Hess AD, Piantadosi S, Noga SJ.
    Bone Marrow Transplant; 1998 Nov 15; 22(10):947-55. PubMed ID: 9849691
    [Abstract] [Full Text] [Related]

  • 10. Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHD.
    Roberts MM, Dyson P, Rawling C, Thorp D, Rawling T, White D, Horvath N, Bardy P, Hui CH, Dart GW, To LB, Hughes TP.
    Cytotherapy; 2003 Nov 15; 5(6):534-41. PubMed ID: 14660049
    [Abstract] [Full Text] [Related]

  • 11. Reduced-intensity conditioning followed by allografting of CD34-selected stem cells and < or =10(6)/kg T cells may have an adverse effect on transplant-related mortality.
    Hartwig UF, Winkelmann N, Wehler T, Kreiter S, Schneider PM, Meyer RG, Ullmann AJ, Huber C, Kolbe K, Herr W.
    Ann Hematol; 2005 May 15; 84(5):331-8. PubMed ID: 15726363
    [Abstract] [Full Text] [Related]

  • 12. Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity.
    Bethge WA, Haegele M, Faul C, Lang P, Schumm M, Bornhauser M, Handgretinger R, Kanz L.
    Exp Hematol; 2006 Dec 15; 34(12):1746-52. PubMed ID: 17157172
    [Abstract] [Full Text] [Related]

  • 13. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA, Faul C, Bornhäuser M, Stuhler G, Beelen DW, Lang P, Stelljes M, Vogel W, Hägele M, Handgretinger R, Kanz L.
    Blood Cells Mol Dis; 2008 Dec 15; 40(1):13-9. PubMed ID: 17869547
    [Abstract] [Full Text] [Related]

  • 14. Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation.
    Baron F, Siquet J, Schaaf-Lafontaine N, Baudoux E, Hermanne JP, Fillet G, Beguin Y.
    Haematologica; 2002 Jan 15; 87(1):78-88. PubMed ID: 11801468
    [Abstract] [Full Text] [Related]

  • 15. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H, Wake A, Yamasaki Y, Izumi Y.
    Rinsho Ketsueki; 2000 Jun 15; 41(6):500-6. PubMed ID: 10921350
    [Abstract] [Full Text] [Related]

  • 16. High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation.
    Passweg JR, Meyer-Monard S, Gregor M, Favre G, Heim D, Ebnoether M, Tichelli A, Gratwohl A.
    Bone Marrow Transplant; 2002 Sep 15; 30(5):267-71. PubMed ID: 12209347
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M, Theuser C, Soucek S, Hölig K, Klingebiel T, Blau W, Fauser A, Runde V, Schwinger W, Rutt C, Ehninger G.
    Haematologica; 2000 Aug 15; 85(8):839-47. PubMed ID: 10942931
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic peripheral blood stem cell transplantation in 23 adult patients with hematologic malignancies: a single-center experience.
    Takenaka K, Shinagawa K, Sunami K, Fujii N, Hiramatsu Y, Maeda Y, Nawa Y, Katayama Y, Teshima T, Ishimaru F, Kiura K, Ikeda K, Harada M.
    Int J Hematol; 2000 Oct 15; 72(3):362-70. PubMed ID: 11185996
    [Abstract] [Full Text] [Related]

  • 19. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT, Zeller W, Stockschläder M, Krüger W, Hoffknecht MM, Zander AR.
    Stem Cells; 1996 Jul 15; 14(4):419-29. PubMed ID: 8843543
    [Abstract] [Full Text] [Related]

  • 20. Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation.
    Martino R, Rovira M, Carreras E, Solano C, Jorge S, De La Rubia J, Caballero MD, de Oteyza JP, Zuazu J, Moraleda JM, Ojeda E, Ferrá C, Serrano D, De La Cámara R, Urbano-Ispízua A, Brunet S, AlloPBSCT and Infectious/Non-infectious Complications Subcommittes of the Grupo Español de Trasplante Hematopoyético (GETH).
    Haematologica; 2001 Oct 15; 86(10):1075-86. PubMed ID: 11602414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.